132 related articles for article (PubMed ID: 20020916)
1. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Kruhlak NL; Choi SS; Contrera JF; Weaver JL; Willard JM; Hastings KL; Sancilio LF
Toxicol Mech Methods; 2008; 18(2-3):217-27. PubMed ID: 20020916
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models.
Contrera JF; Kruhlak NL; Matthews EJ; Benz RD
Regul Toxicol Pharmacol; 2007 Dec; 49(3):172-82. PubMed ID: 17703860
[TBL] [Abstract][Full Text] [Related]
3. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
4. Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds.
Orogo AM; Choi SS; Minnier BL; Kruhlak NL
Mol Inform; 2012 Oct; 31(10):725-39. PubMed ID: 27476455
[TBL] [Abstract][Full Text] [Related]
5. In silico modeling to predict drug-induced phospholipidosis.
Choi SS; Kim JS; Valerio LG; Sadrieh N
Toxicol Appl Pharmacol; 2013 Jun; 269(2):195-204. PubMed ID: 23541745
[TBL] [Abstract][Full Text] [Related]
6. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
[TBL] [Abstract][Full Text] [Related]
7. In Silico Screening of Chemicals for Genetic Toxicity Using MDL-QSAR, Nonparametric Discriminant Analysis, E-State, Connectivity, and Molecular Property Descriptors.
Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
Toxicol Mech Methods; 2008; 18(2-3):207-16. PubMed ID: 20020915
[TBL] [Abstract][Full Text] [Related]
8. In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software.
Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
Regul Toxicol Pharmacol; 2005 Dec; 43(3):313-23. PubMed ID: 16242226
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities.
Frid AA; Matthews EJ
Regul Toxicol Pharmacol; 2010 Apr; 56(3):276-89. PubMed ID: 19941924
[TBL] [Abstract][Full Text] [Related]
10. Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in Rodents.
Matthews EJ; Kruhlak NL; Benz RD; Contrera JF; Marchant CA; Yang C
Toxicol Mech Methods; 2008; 18(2-3):189-206. PubMed ID: 20020914
[TBL] [Abstract][Full Text] [Related]
11. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
Valerio LG; Cross KP
Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
[TBL] [Abstract][Full Text] [Related]
12. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
[TBL] [Abstract][Full Text] [Related]
13. Testing computational toxicology models with phytochemicals.
Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
[TBL] [Abstract][Full Text] [Related]
14. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
15. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
16. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals.
Matthews EJ; Kruhlak NL; Daniel Benz R; Ivanov J; Klopman G; Contrera JF
Regul Toxicol Pharmacol; 2007 Mar; 47(2):136-55. PubMed ID: 17175082
[TBL] [Abstract][Full Text] [Related]
18. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software.
Matthews EJ; Contrera JF
Regul Toxicol Pharmacol; 1998 Dec; 28(3):242-64. PubMed ID: 10049796
[TBL] [Abstract][Full Text] [Related]
19. How does the quality of phospholipidosis data influence the predictivity of structural alerts?
Przybylak KR; Alzahrani AR; Cronin MT
J Chem Inf Model; 2014 Aug; 54(8):2224-32. PubMed ID: 25062434
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
